Trials / Unknown
UnknownNCT03117023
The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer
The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer: A Prospective Randomized Clinical Trial
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Nanjing PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out the effect of Dexmedetomidine for treatment of sleep deprivation, pain relief and postoperative recovery on middle-aged and elderly Patients with Gastric Cancer.
Detailed description
Patients were randomized to receive sufentanil 0.05ug/kh/h + dexmedetomidine 0.1ug/kg/h (DEX group) or sufentanil 0.05ug/kg/h + saline (control group) for 48h. The primary outcome was the total sleep time during the first three days after surgery. The secondary outcomes included pain score, daily sufentanil consumption, time to functional recovery, length of hospital stay and side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexmedetomidine | sufentanil 0.05ug/kh/h + dexmedetomidine 0.1ug/kg/h for 48h after surgery |
Timeline
- Start date
- 2017-04-15
- Primary completion
- 2017-05-15
- Completion
- 2017-06-01
- First posted
- 2017-04-17
- Last updated
- 2017-04-17
Source: ClinicalTrials.gov record NCT03117023. Inclusion in this directory is not an endorsement.